
James William Rogers
Examiner (ID: 13796)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1194 |
| Issued Applications | 502 |
| Pending Applications | 144 |
| Abandoned Applications | 586 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17702604
[patent_doc_number] => 20220202610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CONTACT LENS WITH SUSTAINED RELEASE PROPERTY
[patent_app_type] => utility
[patent_app_number] => 17/139360
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139360 | CONTACT LENS WITH SUSTAINED RELEASE PROPERTY | Dec 30, 2020 | Abandoned |
Array
(
[id] => 18280235
[patent_doc_number] => 20230095707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/790079
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790079 | MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY | Dec 29, 2020 | Pending |
Array
(
[id] => 16778190
[patent_doc_number] => 20210115268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/137564
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137564 | FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF | Dec 29, 2020 | Abandoned |
Array
(
[id] => 16762354
[patent_doc_number] => 20210107935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => NOVEL, HEAVY VITAMIN B12 DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/128511
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128511 | Heavy vitamin B12 derivatives | Dec 20, 2020 | Issued |
Array
(
[id] => 18282966
[patent_doc_number] => 20230098438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/790698
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790698 | OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING | Dec 20, 2020 | Pending |
Array
(
[id] => 18159274
[patent_doc_number] => 20230025866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/787545
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787545 | NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES | Dec 17, 2020 | Pending |
Array
(
[id] => 16719995
[patent_doc_number] => 20210087142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/116501
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116501 | Formulation for soft anticholinergic analogs | Dec 8, 2020 | Issued |
Array
(
[id] => 16717751
[patent_doc_number] => 20210084898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => METHOD OF USING HYDROPHILIZED BACTERICIDAL POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/115709
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/115709 | Method of using hydrophilized bactericidal polymers | Dec 7, 2020 | Issued |
Array
(
[id] => 16760958
[patent_doc_number] => 20210106539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/112674
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112674 | Delivery of drug nanoparticles and methods of use thereof | Dec 3, 2020 | Issued |
Array
(
[id] => 16718679
[patent_doc_number] => 20210085826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/111890
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111890 | Crosslinkable polymer compositions | Dec 3, 2020 | Issued |
Array
(
[id] => 18280579
[patent_doc_number] => 20230096051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/784215
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784215 | CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Dec 3, 2020 | Abandoned |
Array
(
[id] => 18485020
[patent_doc_number] => 20230212340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY
[patent_app_type] => utility
[patent_app_number] => 17/781731
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Dec 3, 2020 | Pending |
Array
(
[id] => 16718678
[patent_doc_number] => 20210085825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/111878
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111878 | Crosslinkable polymer compositions | Dec 3, 2020 | Issued |
Array
(
[id] => 18485020
[patent_doc_number] => 20230212340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY
[patent_app_type] => utility
[patent_app_number] => 17/781731
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Dec 3, 2020 | Pending |
Array
(
[id] => 18273739
[patent_doc_number] => 11612660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Dendrimer compositions and methods for drug delivery to the eye
[patent_app_type] => utility
[patent_app_number] => 17/112255
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 20
[patent_no_of_words] => 20646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112255 | Dendrimer compositions and methods for drug delivery to the eye | Dec 3, 2020 | Issued |
Array
(
[id] => 16883845
[patent_doc_number] => 20210170040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/112541
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112541 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Dec 3, 2020 | Abandoned |
Array
(
[id] => 16876799
[patent_doc_number] => 11026919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Formulation for soft anticholinergic analogs
[patent_app_type] => utility
[patent_app_number] => 17/107942
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9870
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17107942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/107942 | Formulation for soft anticholinergic analogs | Nov 29, 2020 | Issued |
Array
(
[id] => 16710312
[patent_doc_number] => 20210077459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/107908
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17107908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/107908 | Formulation for soft anticholinergic analogs | Nov 29, 2020 | Issued |
Array
(
[id] => 18363247
[patent_doc_number] => 20230144838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/778242
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778242 | THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS | Nov 16, 2020 | Pending |
Array
(
[id] => 18363247
[patent_doc_number] => 20230144838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/778242
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778242 | THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS | Nov 16, 2020 | Pending |